AB-Pred - About the company
AB-Pred is an unfunded company based in Aalborg (Denmark), founded in 2022 by Kenneth Kastaniegaard. It operates as an Antibody prediction software. AB-Pred has not raised any funding yet. The company has 8 active competitors, including 2 that are funded. Its top competitors include companies like Benchsci, Ability and Nona Biosciences.
Company Details
Antibody prediction software. The company offers AI-assisted software to identify and predict the right candidate or recombinant protein performance in the clinical development phase for researchers and CRO.
- Website
- abpred.com
- Email ID
- *****@abpred.com
- Phone Number
- +45 **********
Key Metrics
Founded Year
2022
Location
Aalborg, Denmark
Stage
Unfunded
Ranked
4th among 8 active competitors
Employee Count
1 - 10 as on Jul 01, 2024
Sign up to download AB-Pred's company profile
AB-Pred's funding and investors
AB-Pred has not raised any funding rounds yet.
AB-Pred's founders and board of directors
Founder? Claim ProfileThe founders of AB-Pred is Kenneth Kastaniegaard. Kenneth Kastaniegaard is the CEO of AB-Pred.
Here are the details of AB-Pred's key team members:
- Kenneth Kastaniegaard: Co-Founder & CEO of AB-Pred and founder of 2 other companies, Omics Studio and Biogenity. Contact Info: 1 email address and 1 phone number
View details of AB-Pred's Founder profiles and Board Members
AB-Pred's employee count trend
AB-Pred has 1 - 10 employees as of Jul 24. Here is AB-Pred's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AB-Pred's Competitors and alternates
Top competitors of AB-Pred include Benchsci, Ability and Nona Biosciences. Here is the list of Top 10 competitors of AB-Pred, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of an AI platform for understanding disease biology | $170M | 68/100 | ||
2nd | Developer of modulating biotherapeutics to address cancer and autoimmune diseases | $30M | 59/100 | ||
3rd | Nona Biosciences 2022, Cambridge (United States), Unfunded | Provider of data mining tools for analysing and recommending antibodies | - | - | 35/100 |
4th | Antibody prediction software | - | - | 24/100 | |
5th | Deep Biologics 2020, Toronto (Canada), Funding Raised | Provider of an AI-based antibody mining and screening platform for R&D work | - | 22/100 | |
6th | Provider of cell therapy and antibody services | - | 20/100 | ||
7th | Provider of data mining tools for analyzing and recommending antibodies for expirments | - | - | 19/100 | |
8th | Provider of data mining tools for analyzing and recommending antibodies for experiments | - | 17/100 |
Looking for more details on AB-Pred's competitors? Click here to see the top ones
AB-Pred's Investments and acquisitions
AB-Pred has made no investments or acquisitions yet.
Reports related to AB-Pred
Here is the latest report on AB-Pred's sector:
Are you a Founder ?
FAQs about AB-Pred
Explore our recently published companies
- Primary Payments - 1997 founded, Unfunded company
- Preservationtrust.com - 2003 founded, Unfunded company
- Prepaidcredit.com - 2000 founded, Unfunded company
- Prentice Technologies - United States based, 2011 founded, Unfunded company
- Thompson Roofing - United States based, 2013 founded, Unfunded company
- Unwaste - Amsterdam based, 2018 founded, Unfunded company
